Article
Role of CD21 antigen in diffuse large B-cell lymphoma and its clinical significance.
British journal of haematology - 1 Nov 2004
Otsuka Masaki, Yakushijin Yoshihiro, Hamada Makoto, Hato Takaaki, Yasukawa Masaki, Fujita Sigeru
Abstract excerpt
Recent advances in immunological and molecular technology have prompted proposals to change tumour classification and treatment strategies. Cell surface antigens are now easy to access, and tumour origins and clinical characteristics are now readily identifiable. However, in diffuse large B-cell lymphoma (DLBCL), one of the heterogeneous forms of haematological malignancy, the clinical significance of tumour...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
